-
公开(公告)号:US08603532B2
公开(公告)日:2013-12-10
申请号:US13122615
申请日:2009-10-20
CPC分类号: A61K9/48 , A61K9/143 , A61K31/555 , A61K33/24 , A61K47/48092 , A61K47/48869 , A61K47/48915 , A61K47/549 , A61K47/6925 , A61K47/6937 , B82Y5/00
摘要: The present invention provides compositions, preparations, formulations, kits, and methods useful for treating subjects having cancer or at risk of developing cancer. Some embodiments of the invention may comprise a composition comprising a plurality of particles comprising a platinum(IV) therapeutically active precursor.
摘要翻译: 本发明提供了可用于治疗患有癌症或有癌症发生危险的受试者的组合物,制剂,制剂,试剂盒和方法。 本发明的一些实施方案可以包含包含多个包含铂(IV)治疗活性前体的颗粒的组合物。
-
公开(公告)号:US20110300219A1
公开(公告)日:2011-12-08
申请号:US13122615
申请日:2009-10-20
IPC分类号: A61K9/14 , A61P35/00 , A61K39/00 , A61K33/00 , A61K31/282
CPC分类号: A61K9/48 , A61K9/143 , A61K31/555 , A61K33/24 , A61K47/48092 , A61K47/48869 , A61K47/48915 , A61K47/549 , A61K47/6925 , A61K47/6937 , B82Y5/00
摘要: The present invention provides compositions, preparations, formulations, kits, and methods useful for treating subjects having cancer or at risk of developing cancer. Some embodiments of the invention may comprise a composition comprising a plurality of particles comprising a platinum(IV) therapeutically active precursor.
摘要翻译: 本发明提供了可用于治疗患有癌症或有癌症发生危险的受试者的组合物,制剂,制剂,试剂盒和方法。 本发明的一些实施方案可以包含包含多个包含铂(IV)治疗活性前体的颗粒的组合物。
-
公开(公告)号:US20130017265A1
公开(公告)日:2013-01-17
申请号:US13515668
申请日:2010-12-16
申请人: Omid C. Farokhzad , Nagesh Kolishetti , Shanta Dhar , Stephen J. Lippard , Robert S. Langer , Pedro M. Valencia
发明人: Omid C. Farokhzad , Nagesh Kolishetti , Shanta Dhar , Stephen J. Lippard , Robert S. Langer , Pedro M. Valencia
IPC分类号: A61K31/80 , A61K31/787 , C08G63/91 , A61P37/04 , A61P35/00 , A61K9/14 , A61K31/785
CPC分类号: A61K45/06 , A61K47/593 , A61K47/60 , A61K47/6937
摘要: Delivery compositions are provided that include two or more active agents, wherein at least one active agent is conjugated to a polymer. The delivery compositions allow for controlled release of multiple active agents, including active agents with varying solubility, charge, and/or molecular weight.
摘要翻译: 提供包含两种或更多种活性剂的递送组合物,其中至少一种活性剂与聚合物缀合。 递送组合物允许控制释放多种活性剂,包括具有不同溶解度,电荷和/或分子量的活性剂。
-
-